PPA
BMY.RT

Parametric Portfolio Associates’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Parametric Portfolio Associates’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,595
Closed -$7K – 4130
2020
Q4 		$7K Sell
10,595
-22,144
-68% -$47.2K ﹤0.01% 3983
2020
Q3 		$74K Sell
32,739
-11,528
-26% -$32.9K ﹤0.01% 3836
2020
Q2 		$158K Buy
44,267
+3,058
+7% +$11K ﹤0.01% 3691
2020
Q1 		$157K Buy
41,209
+12,359
+43% +$40.7K ﹤0.01% 3617
2019
Q4 		$87K Buy
+28,850
New +$75K ﹤0.01% 3877

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Parametric Portfolio Associates's BMY.RT Position: Q1 2021 in Review

Parametric Portfolio Associates sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 10,595 shares — an estimated $7K sold.

Parametric Portfolio Associates first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $158K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Parametric Portfolio Associates reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 10,595 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $7K.
  • Parametric Portfolio Associates first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Parametric Portfolio Associates's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $158K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Parametric Portfolio Associates's 13F filing for Q1 2021, filed 17 May 2021.